Join the Benicar HCT group to help and get support from people like you.
Benicar HCT News
FDA Medwatch Alert: Olmesartan: Drug Safety Communication - FDA Review Finds Cardiovascular Risks for Diabetics Not Conclusive
Includes: Benicar, Benicar HCT, Azor, Tribenzor, and Generics [Posted 06/24/2014] ISSUE: FDA has completed its safety review and has found no clear evidence of increased cardiovascular risks...
FDA Medwatch Alert: Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like...
FDA Medwatch Alert: Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed
[UPDATED 06/02/2011] FDA’s meta-analysis of 31 randomized controlled trials comparing ARBs to other treatment found no evidence of an increased risk of incident (new) cancer, cancer-related death, b...
FDA Medwatch Alert: Benicar (olmesartan): Ongoing Safety Review
[UPDATED 04/14/2011] After reviewing the results of the ROADMAP and ORIENT trials, FDA has determined that the benefits of Benicar continue to outweigh its potential risks when used for the treatment...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
High Blood Pressure, Hypertension